The Lancet Gastroenterology & Hepatology in conversation with

James Alexander on immune responses to COVID-19 vaccination in patients with IBD

October 05, 2022 The Lancet Gastroenterology & Hepatology
The Lancet Gastroenterology & Hepatology in conversation with
James Alexander on immune responses to COVID-19 vaccination in patients with IBD
Show Notes

James Alexander (Imperial College London) discusses the latest findings from the VIP case-control study, which is investigating COVID-19 vaccine immune responses in immunosuppressed patients with inflammatory bowel disease.

Read the full article:
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP)

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv